Overview

Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Pioglitazone as an adjunct to Citalopram is effective in treatment of moderate to severe depression
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tehran University of Medical Sciences
Treatments:
Chlordiazepoxide
Citalopram
Dexetimide
Pioglitazone